First-in-human study to assess the safety, tolerability and pharmacokinetics following single-dose administration of ABT-981 in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 18 Mar 2017
At a glance
- Drugs Lutikizumab (Primary) ; Lutikizumab (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors AbbVie
- 18 Mar 2017 Results (n=78) from this and one other phase 1 study presented at the 118th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 06 May 2016 Results from this trial and other trial (see trial - 222237) published in the Journal of Clinical Pharmacology
- 01 Dec 2014 New trial record